MANAGEMENT TEAM EXECUTIVES

Aristotle G. Kalivretenos, Ph. D.
Chief Operating Officer, Aurora Analytics, LLC
Adjunct Assistant Professor of Chemistry, UMBC

Dr. Kalivretenos has expertise in solid/solution-phase synthetic methodology and total synthesis, with particular emphasis in amine/peptide/protein modification and fluorescent chemosensors. He earned a Ph.D. in organic chemistry from Colorado State University followed by a post-doctoral fellowship, focusing in the CNS area, at Columbia University. After joining faculty at UMBC in 1992, Dr. Kalivretenos’ research focused on bio-organic studies of channel forming peptides, including the development of solid-phase and solution-phase synthetic methodology for amine/peptide/protein synthesis and modification. A practical outcome of this work has been the ongoing development of diagnostic agents for food safety applications. Dr. Kalivretenos subsequently left to serve as Scientist II at Sensors for Medicine and Science, Inc. from 1998 until 2004, focusing on the design and development of novel fluorescent glucose recognition chemistry as part of the development of an implantable continuous glucose sensor/monitor for diabetics. Dr. Kalivretenos has project management experience, including expertise in FDA and OSHA compliance requirements.

William R. LaCourse, Ph.D.
Chief Executive Officer, Aurora Analytics, LLC
Professor of Analytical Chemistry, UMBC

Dr. LaCourse’s research interests include basic and applied research on hydrodynamic electroanalytical techniques in liquid chromatography and capillary electrophoresis, adsorption phenomena at noble metal electrodes, and advanced sample preparation techniques (e.g., microdialysis and pressurized-fluid extraction). He received his Ph.D. in Analytical Chemistry from Northeastern University. After completing a postdoctoral appointment at Ames Laboratory, he held the position of Scientist at Iowa State University/Ames Laboratory until he joined the faculty at the UMBC in 1992. In addition, he has five years of experience in the pharmaceutical industry on the development of product assays of both human and veterinarian formulations.

Ron Wilson, MBA, CPA
Chief Financial Officer

Mr. Wilson is the Principal of StrategicCFO, a professional financial management company. Mr. Wilson has served as CFO for a large health care organization and as an outside financial advisor to many privately-held companies in a range of industries. He has a Bachelors degree in Business Administration from Towson University. His Master’s of Business Administration is in Finance from the University of Baltimore. Mr. Wilson is a certified public accountant.